Home/Filings/4/0001209191-20-023862

4//SEC Filing

Column Group II GP, LP 4

Accession 0001209191-20-023862

CIK 0001426332other

View on SEC.gov Company Profile

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 7:21 PM ET

Size

25.7 KB

Accession

0001209191-20-023862

Insider Transaction Report

Form 4

Period: 2020-04-03

NGM BIOPHARMACEUTICALS INCNGM

COLUMN GROUP II, LP

10% Owner

Transactions

Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total
Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total

Holdings

Common Stock
15,000
Common Stock
16,166,907

COLUMN GROUP GP, LP

10% Owner

Transactions

Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total
Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total

Holdings

Common Stock
16,166,907
Common Stock
15,000

Ponoi Management, LLC

10% OwnerOther

Transactions

Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total
Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total

Holdings

Common Stock
16,166,907
Common Stock
15,000

Ponoi Capital II, LP

10% Owner

Transactions

Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total
Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total

Holdings

Common Stock
15,000
Common Stock
16,166,907

Ponoi II Management, LLC

10% OwnerOther

Transactions

Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total
Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total

Holdings

Common Stock
16,166,907
Common Stock
15,000

COLUMN GROUP L P

10% Owner

Transactions

Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total
Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total

Holdings

Common Stock
16,166,907
Common Stock
15,000

Column Group Management LP

10% Owner

Transactions

Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total
Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total

Holdings

Common Stock
16,166,907
Common Stock
15,000

PONOI CAPITAL, LP

10% Owner

Transactions

Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total
Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total

Holdings

Common Stock
16,166,907
Common Stock
15,000

Column Group II GP, LP

10% OwnerOther

Transactions

Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total
Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total

Holdings

Common Stock
16,166,907
Common Stock
15,000

Kutzkey Tim

10% OwnerOther

Transactions

Purchase
Common Stock
2020-04-03$12.41/sh+14,587$181,025→ 1,303,741 total
Purchase
Common Stock
2020-04-07$14.38/sh+123,728$1,779,209→ 1,427,469 total

Holdings

Common Stock
16,166,907
Common Stock
15,000

Footnotes (12)

[F1]Consists of 6,851 shares of Common Stock held directly by The Column Group III, LP ("TCG III LP") and 7,736 shares of Common Stock held directly by The Column Group III-A, LP ("TCG III-A LP").
[F10]The securities are directly held by Ponoi LP, and indirectly held by Ponoi Management, LLC ("Ponoi LLC"), the general partner of Ponoi LP. The managing partners of Ponoi LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
[F11]The securities are directly held by Ponoi II LP, and indirectly held by Ponoi II Management, LLC ("Ponoi II LLC"), the general partner of Ponoi II LP. The managing partners of Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
[F12]These securities are owned solely by Tim Kutzkey.
[F2]The securities are directly held by TCG III LP, and indirectly held by The Column Group III GP, LP ("TCG III GP"), the general partner of TCG III. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
[F3]The securities are directly held by TCG III-A LP, and indirectly held by TCG III GP, the general partner of TCG III-A LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
[F4]Consists of 58,107 shares of Common Stock held directly by TCG III LP and 65,621 shares of Common Stock held directly by TCG III-A LP.
[F5]Consists of 11,103,333 shares of Common Stock held directly by The Column Group, LP ("TCG LP"), 2,265,758 shares of Common Stock held directly by The Column Group II, LP ("TCG II LP"), 100,000 shares of Common Stock held directly by The Column Group GP, LP ("TCG GP"),100,000 shares of Common Stock held directly by The Column Group Management, LP ("TCGM LP"), 1,298,908 shares of Common Stock held directly by Ponoi Capital, LP ("Ponoi LP"), and 1,298,908 shares of Common Stock held directly by Ponoi Capital II, LP ("Ponoi II LP").
[F6]The securities are directly held by TCG LP, and indirectly held by TCG GP, the general partner of TCG LP. The managing partners of TCG GP are David Goeddel and Peter Svennilson. The managing partners of TCG GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
[F7]The securities are directly held by TCG II LP, and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
[F8]The securities are directly held by TCG GP. The managing partners of TCG GP are David Goeddel and Peter Svennilson. The managing partners of TCG GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
[F9]The securities are directly held by TCGM LP. The managing partners of TCGM LP are David Goeddel and Peter Svennilson. The managing partners of TCGM LP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001645333

Filing Metadata

Form type: 4
Filed: Apr 6, 8:00 PM ET
Accepted: Apr 7, 7:21 PM ET
Size: 25.7 KB

View on SEC.gov